Académique Documents
Professionnel Documents
Culture Documents
Review
a r t i c l e
i n f o
Article history:
Received 17 September 2015
Received in revised form 26 October 2015
Accepted 27 October 2015
Available online 1 November 2015
Keywords:
Xylanase
Lignocellulose
Water hyacinth
Recombinant DNA technology
Biofuel
a b s t r a c t
Xylanases are classied under glycoside hydrolase families which represent one of the largest groups of
commercial enzymes. Depolymerizing xylan molecules into monomeric pentose units involves the synergistic action of mainly two key enzymes which are endo--xylanase and -xylosidase. Xylanases are
different with respect to their mode of action, substrate specicities, biochemical properties, 3D structure
and are widely produced by a spectrum of bacteria and fungi. Currently, large scale production of xylanase
can be produced through the application of genetic engineering tool which allow fast identication of
novel xylanase genes and their genetic variations makes it an ideal enzymes. Due to depletion of fossil fuel, there is urgent need to nd out environment friendly and sustainable energy sources. Therefore,
utilisation of cheap lignocellulosic materials along with proper optimisation of process is most important
for cost efcient ethanol production. Among, various types of lignocellulosic substances, water hyacinth,
a noxious aquatic weed, has been found in many tropical. Therefore, the technological development for
biofuel production from water hyacinth is becoming commercially worthwhile. In this review, the classication and mode of action of xylanase including genetic regulation and strategy for robust xylanase
production have been critically discussed from recent reports. In addition various strategies for cost effective biofuel production from water hyacinth including chimeric proteins design has also been critically
evaluated.
2015 Elsevier B.V. All rights reserved.
Contents
1.
2.
3.
Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1042
Xylanase: its classication and mode of action . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1043
2.1.
Family 5 glycoside hydrolase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1043
2.2.
Family 8 glycoside hydrolase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1043
2.3.
Family 10 glycoside hydrolase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1043
2.4.
Family 11 glycoside hydrolase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1044
2.5.
Family 19 glycoside hydrolase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1044
2.6.
Family 30 glycoside hydrolase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1044
Strategy for xylanase production . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1045
3.1.
Strategy with wild producer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1045
3.2.
Strategy for recombinant producer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1045
3.2.1.
Cloning of xylanase gene for enhanced xylanase expression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1045
3.2.2.
Mutagenesis for enhanced xylanase expression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1045
Corresponding author.
E-mail address: bbhunia@gmail.com (B. Bhunia).
http://dx.doi.org/10.1016/j.ijbiomac.2015.10.086
0141-8130/ 2015 Elsevier B.V. All rights reserved.
1042
4.
5.
6.
7.
1. Introduction
Biotechnology is one important scientic eld where the highest development during the last few decades has been taken place.
It is the integration of biological, physical and engineering sciences in order to achieve technological application using biological
systems [1,2]. Microorganisms such as bacteria, yeasts and lamentous fungi are used in most biotechnological processes, however
vascular plants, algae and even animal tissue can also be utilised
[3]. Recent application of biotechnology has been focused on biological products such as enzymes, antibiotics, hormones etc. One
of the advantages of the advanced biotechnology process over
classical biotechnology is that the mass balance for biotechnological products and control mechanism can easily evaluated [3,4].
Nevertheless, there have been very rapid application of genetic
engineering in bioprocess leading to optimisation of the production of established or novel metabolites of commercial importance
[2,4].
Enzymes are used to produce a wide range of biotechnological
products utilised by the food, chemical, and allied industries and
have been already recognised as valuable catalysts for production
of ne chemicals and pharmaceuticals and several organic transformations [2,5,6]. The estimated value of world enzyme market
was about US $3060 billion in 2010 [7]. Table 1 summarises the
major producers of industrial enzymes. The majority of the industrial enzyme production belongs to Novo Industri A/S (Denmark),
Danisco/Genencor (Denmark and USA), BASF (Germany) and DSM
(Netherlands), controlling about 73% of the market between them
[2,8]. It has been found that most of the enzymes industrially produced so far function in a narrow range of temperature, pH and ionic
strength which are prerequisite for the commercial application of
these enzymes [9,10]. Hence, the search for a new enzyme having wide working range of those function parameters is a primary
requirement [7].
Hydrolase represents one of the largest groups of industrial
enzymes and accounts for about 75% of total worldwide enzyme
sales. The carbo-hydrolases, signify one of the second largest
groups of industrial enzymes which can be produced by bacteria,
fungi, animal and plant cells [11]. Carbo-hydrolases include cellulases and hemicellulase which act on cellulose and hemicellulose
which are two major fundamental components of lignocellulose
generated through photosynthesis in plant. These two carbohydrate polymers are covalent cross-linked with a non-carbohydrate
Table 1
Major producers of industrial enzymes [2].
Company
45
17
4
5
29
1043
Fig. 1. Biological assembly image for 3GTN (crystal structure of XynC from Bacillus subtilis 168. Protein chains are coloured from the N-terminal to the C-terminal
using a rainbow (spectral) colour gradient) (http://www.rcsb.org/pdb/home/home.
do). (For interpretation of the references to colour in this gure legend, the reader
is referred to the web version of this article.)
xylotriose. It has been found that the subsites (3 to +3) are responsible to give a depth insight into the structurefunction relationship
of family 8 glycoside hydrolases. Furthermore, the mechanism of
action of GH-8 members is described mentioning that the substrate
hydrolysis is preceded by a conformational change without the
substrate ground-state chair conformation [28].
1044
Fig. 3. Biological assembly image for 3NIY (crystal structure of native xylanase 10B
from Thermotoga petrophila RKU-1. Protein chains are coloured from the N-terminal
to the C-terminal using a rainbow (spectral) colour gradient) (http://www.rcsb.org/
pdb/home/home.do). (For interpretation of the references to colour in this gure
legend, the reader is referred to the web version of this article.)
Fig. 4. Biological assembly image for 1C5H (hydrogen bonding and catalysis: an
unexpected explanation for how a single amino acid substitution can change the ph
optimum of a glycosidase. Protein chains are coloured from the N-terminal to the
C-terminal using a rainbow (spectral) colour gradient) (http://www.rcsb.org/pdb/
home/home.do). (For interpretation of the references to colour in this gure legend,
the reader is referred to the web version of this article.)
Fig. 5. Biological assembly image for 4HU8 (crystal structure of a bacterial Ig-like
domain containing GH 10 xylanase from termite gut. Protein chains are coloured
from the N-terminal to the C-terminal using a rainbow (spectral) colour gradient)
(http://www.rcsb.org/pdb/home/home.do). (For interpretation of the references to
colour in this gure legend, the reader is referred to the web version of this article.)
Fig. 6. Biological assembly image for 4QB1 (structure of CBM35 from Paenibacillus
barcinonensis protein chains are coloured from the N-terminal to the C-terminal
using a rainbow (spectral) colour gradient) (http://www.rcsb.org/pdb/home/home.
do). (For interpretation of the references to colour in this gure legend, the reader
is referred to the web version of this article.)
1045
1046
three amino acids (Cys-5, Pro-9, and His-14) is responsible for thermal stability which was replaced in mutant [60].
3.2.2.2. Mutagenesis for enhanced pH stable xylanase expression. The
alkaline stability of the xylanase from T. lanuginosus was enhanced
by directed evolution using error-prone PCR mutagenesis. The positive clone which produced clear zones on pH 9 and 12 of xylan agar
plates were screened. It was found that the variant NC38 can withstand at pH 10 retaining 84% activity for 90 min at 60 C which is
higher than parental enzyme. The variant NC38 was further cloned
into pBGP1 under the control of GAP to promote and pET22b(+)
expression in P. pastoris and Escherichia coli BL21, respectively. A
higher extracellular expression of xylanase was found in P. pastoris (261.7 U ml1 ) in comparison with E. coli (47.9 U ml1 ) and
total activity obtained in P. pastoris was 545-fold higher than E. coli.
This alkaline stable mutated xylanase favours the application of this
enzyme in the pulp and paper industry [61].
The pH-dependent activity was also carried out by mutagenesis
and the pH dependency of wild type B. circulans xylanase (BcX) is
due to the pKa values of its nucleophile Glu78 and general acid/base
Glu172. Therefore several strategies were applied by manipulating
these pKa values to nd out the shifting of the pH (opt). It has been
found that random succinylation had no signicant effect on shifting of pH optimum of xylanase activity as it is expected to change
of global charge. Mutation has further carried out residues near
or within the active site of BcX, however, little effect was found
regarding change of pH optimum due to lowering the apparent pKa
value of Glu78.
Substitution of Glu172 with a His resulted lowered the pH (opt)
of BcX from 5.6 to 4.7 with retaining 8% activity towards a xylobioside substrate His lowered the pH (opt) of BcX from 5.6 to 4.7
while retaining 8% activity towards a xylobioside substrate. It was
revealed by NMR spectroscopy that utilizing a reverse protonation mechanism was applied in spite of the opposite charges of
the introduced residues. The reverse protonation mechanism indicates that the pKa value of the general acid is lower than that of the
nucleophile, and therefore, only a small fraction of population of
enzyme is in a catalytically competent ionisation state. However,
it is a fact that overall activity is maintained due to the increased
strength of the general acid [62].
3.2.2.3. Look-Through Mutagenesis (LTMTM ) and Combinatorial Benecial Mutagenesis (CBMTM ). Recently Look-Through Mutagenesis
(LTMTM ) and Combinatorial Benecial Mutagenesis (CBMTM ) are
commonly used in mutagenesis. LTM is used for rapid screening of
amino acids at selected positions in the protein sequence which can
introduce favourable properties whereas CBM is a method to identify the best assembly of individual mutations. These techniques are
advantageous as they do not required high-throughput screening or
special equipment. These techniques are designed to get the maximum information through the small, chemistry-driven libraries
which lead to identify informative leads. Still, there are several
reports which found that several rational and random mutagenesis
strategies have been reported to improve the favourable properties of xylanase. However, Look-Through Mutagenesis (LTM) and
Combinatorial Benecial Mutagenesis (CBM) are more reliable on
structural data, which are not always found to effectively search
the sequence space using random/saturation mutagenesis. Iterative saturation mutagenesis (ISM) focuses on small regions of the
protein which is determined from examining statistical analyses
of sequence/function/stability relationships and protein structure
while LTM/CBM scans the whole protein. LTM/CBM would most
likely be used to nd out the benecial mutations which are present
throughout the protein. Both methods incorporate data into design
libraries with reduced numbers of variants which will lower the
cost of the screening effort [63]. LTM/CBM was applied to nd
1047
out the thermostable mutants of xylanase from Hypocrea jecorina (GenBank Accession No. P36217), having the 32-residue signal
sequence. The LTM xylanase libraries were prepared by polymerase
cycling assembly (PCA) and further cloned through expression vector pPICZC into P. pastoris. Each oligonucleotide contributes to a
21 base pair homology with its reverse-orientated neighbouring
oligonucleotide. The complete xylanase gene was assembled with
16 oligonucleotides, containing an average length of 63 nucleotides.
Ten selected benecial xylanase mutations were obtained through
the LTM screens to improve thermo-tolerance. These mutants were
used to combinatorially build a CBM library of 360 mutants by the
use of degenerate oligonucleotides. These oligonucleotides were
further designed to limit the number of non-consensus amino acids
created by the degenerate oligonucleotides. CBM library was produced by PCR by the degenerate oligonucleotides. The library was
further sub-cloned into the pPICZC plasmid and transformed into
the P. pastoris X-33 strain and six hundred clones were analysed
for higher temperature optimum for xylanase activity. A diverse
set of novel mutations including N71D, Y73G, T95G and Y96Q were
discovered. It is interesting to note that when a single construct
(Hjx-81) was made with these mutations and the puried protein
retained its activity even after heating at 100 C for 20 min. Therefore, LTM/CBM method is a time-effective method which should
be used for quickly improving the favourable properties of other
industrial and therapeutic enzymes [63].
1048
1049
1050
found to be 550 IU mL1 and 1.73 g/L respectively with a very high
overall volumetric productivity of 22,000 IU L1 h1 [117].
It has been found that the shake ask experiments are not appropriate for production of recombinant xylanase which is due to fact
that relatively uncontrolled environment in shake ask leads to
unwanted proteolysis and revert to the wild strain. Therefore, a
fed-batch fermentation system may be appropriate for recombinant xylanase production. Punt et al. (2011) reported that a 25 L
fermenter setup may be appropriate for 1 g/L recombinant protein
production using A. niger through fed batch fermentation. A 200 mL
pre-culture of potato dextrose broth containing 1 106 spores
ml1 was inoculated in the fermenter. Media composition at fermenter was glucose (30 g/L), NaNO3 (10 g/L), MgSO4 7H2 O (0.8 g/L),
KH2 PO4 (2 g/L), CaCl2 2H2 O (0.1 g/L), yeast extract (5 g/L), tryptone
(5 g/L). The experiment was carried out at pH 4.5, T = 30 C, airow of
1.2 L/min. DO was required to maintain about 20% through adjustment of agitation speed which was in the range of 400800 rpm.
Pure oxygen was sparged if agitation speed was not sufcient to
maintain DO value of 20%. The feeding has normally started 24 h
after the start of the fermentation at the rate of 5 g/h. The composition of feed medium was glucose (200 g/L), KH2 PO4 (10 g/L), NaNO3
(30 g/L), yeast extract (10 g/L), tryptone (10 g/L). The fed batch fermentation was terminated 4856 h after start of the feeding [118].
Fig. 9. Effect of agitation rate on fungal morphology during production of xylanase by M. albomyces IITD3A (a) at 400 rpm and (b) at 600 rpm.
1051
7. Conclusion
The value added product such as biofuel from waste like water
hyacinth has received much attention globally by the researchers.
The ethanol production from lignocellulosic material includes three
steps. They are pretreatment, saccharication and fermentation.
The objective is the depolymerisation of lignocellulosic biomass
into fermentable sugars. Pretreatment is normally carried out by
either chemical route using acid/base or biological route using
enzymes/microbial cells. However, during chemical treatment formation of furfural and 5-hydroxymethylfurfural which are sugar
degradation products will inhibit microbial growth in the successive fermentation steps. It has been found that no such products are
formed during enzyme treatment as it is usually conducted under
mild conditions. The enzyme treatment methods are normally
carried out using xylanase and cellulase which can be produced
widely by a spectrum of bacteria and fungi. Filamentous fungi have
potential for industrial production of xylanase. It is obvious that
large scale xylanase can be produced through random mutagenesis,
site specic mutagenesis, Iterative Saturation Mutagenesis (ISM),
Look-Through Mutagenesis (LTMTM ) and Combinatorial Benecial
Mutagenesis (CBMTM ) using applications of genetic engineering
tool. It is obvious that chimeric proteins of cellulose and xylanase
may improve enzyme-based industrial bioprocesses by providing
1052
[30]
[31]
References
[1] A. Moser, Bioprocess Technology, Springer-Verlag, New York, USA, 1988.
[2] C. Ratledge, B. Kristiansen, Basic Biotechnology, 3rd ed., Cambridge
University Press India Pvt. Ltd., New Delhi, 2008.
[3] M.L. Shuler, F. Kargi, Bioprocess Engineering: Basic Concepts, Practice Hall of
India Private Limited, New Delhi, 2008.
[4] M. Moo-Young, Y. Chisti, Biochemical engineering in biotechnology, Pure
Appl. Chem. 66 (1994) 117136.
[5] B. Bhunia, B. Basak, T. Mandal, P. Bhattacharya, A. Dey, Effect of pH and
temperature on stability and kinetics of novel extracellular serine alkaline
protease (70 kDa), Int. J. Biol. Macromol. 54 (2013) 18.
[6] B. Bhunia, D. Dutta, S. Chaudhuri, Extracellular alkaline protease from
Bacillus licheniformis NCIM-2042: improving enzyme activity assay and
characterization, Eng. Life Sci. 11 (2011) 207215.
[7] S. Savitha, S. Sadhasivam, K. Swaminathan, F.H. Lin, Fungal protease:
production, purication and compatibility with laundry detergents and
their wash performance, J. Inst. Chem. Eng. 42 (2011) 298304.
[8] B. Jaouadi, S.E. Chaabouni, M. Rhimi, S. Bejar, Biochemical and molecular
characterization of a detergent-stable serine alkaline protease from Bacillus
pumilus CBS with high catalytic efciency, Biochimie 90 (2008) 12911305.
[9] B. Bhunia, B. Basak, A. Dey, A review on production of serine alkaline
protease by Bacillus spp, J. Biochem. Technol. 3 (2012) 448457.
[10] B. Bhunia, K. Behera, A. Baquee, H. Sharma, Optimization of alkaline protease
activity from Bacillus subtilis 2724 by response surface methodology (RSM),
Int. J. Biol. Sci. Eng. 1 (2010) 158169.
[11] M.K. Bhat, Cellulases and related enzymes in biotechnology, Biotechnol.
Adv. 18 (2000) 355383.
[12] M.L. Polizeli, A.C. Rizzatti, R. Monti, H.F. Terenzi, J.A. Jorge, D.S. Amorim,
Xylanases from fungi: properties and industrial applications, Appl.
Microbiol. Biotechnol. 67 (2005) 577591.
[13] R.A. Prade, Xylanases: from biology to biotechnology, Biotechnol. Genet.
Eng. Rev. 13 (1996) 101131.
[14] K.L. Eriksson, H. Bermek, Lignin, lignocellulose, ligninase, Appl. Microbiol.
Ind. (2009) 373384.
[15] B.C. Saha, Hemicellulose bioconversion, J. Ind. Microbiol. Biotechnol. 30
(2003) 279291.
[16] Q.K. Beg, M. Kapoor, L. Mahajan, G.S. Hoondal, Microbial xylanases and their
industrial applications: a review, Appl. Microbiol. Biotechnol. 56 (2001)
326338.
[17] K. Li, P. Azadi, R. Collins, J. Tolan, J.S. Kim, K.L. Eriksson, Relationships
between activities of xylanases and xylan structures, Enzyme Microb.
Technol. 27 (2000) 8994.
[18] . Cano, C. Palet, Xylooligosaccharide recovery from agricultural biomass
waste treatment with enzymatic polymeric membranes and
characterization of products with MALDI-TOF-MS, J. Membr. Sci. 291 (2007)
96105.
[19] N. Kulkarni, A. Shendye, M. Rao, Molecular and biotechnological aspects of
xylanases, FEMS Microbiol. Rev. 23 (1999) 411456.
[20] S. Ahmed, S. Riaz, A. Jamil, Molecular cloning of fungal xylanases: an
overview, Appl. Microbiol. Biotechnol. 84 (2009) 1935.
[21] A. Knob, C. Terrasan, E. Carmona, -Xylosidases from lamentous fungi: an
overview, World J. Microbiol. Biotechnol. 26 (2010) 389407.
[22] T. Collins, C. Gerday, G. Feller, Xylanases, xylanase families and
extremophilic xylanases, FEMS Microbiol. Rev. 29 (2005) 323.
[23] D. Verma, T. Satyanarayana, Molecular approaches for ameliorating
microbial xylanases, Bioresour. Technol. 117 (2012) 360367.
[24] Z. Taibi, B. Saoudi, M. Boudelaa, H. Trigui, H. Belghith, A. Gargouri, A.
Ladjama, Purication and biochemical characterization of a highly
thermostable xylanase from Actinomadura sp. strain Cpt20 isolated from
poultry compost, Appl. Biochem. Biotechnol. 166 (2012) 663679.
[25] J.T.M. Buchert, A. Kantelinen, L. Viikari, Application of xylanases in the pulp
and paper industry, Bioresour. Technol. 50 (1995) 6572.
[26] V. Juturu, J.C. Wu, Microbial xylanases: engineering, production and
industrial applications, Biotechnol. Adv. 30 (2012) 12191227.
[27] F.J. St John, D.K. Godwin, J.F. Preston, E. Pozharski, J.C. Hurlbert,
Crystallization and crystallographic analysis of Bacillus subtilis xylanase C,
Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 65 (2009) 499503.
[28] D. De Vos, T. Collins, W. Nerinckx, S.N. Savvides, M. Claeyssens, C. Gerday, G.
Feller, J. Van Beeumen, Oligosaccharide binding in family 8 glycosidases:
crystal structures of active-site mutants of the beta-1, 4-xylanase pXyl from
Pseudoaltermonas haloplanktis TAH3a in complex with substrate and
product, Biochemistry 45 (2006) 47974807.
[29] C.R. Santos, A.N. Meza, Z.B. Hoffmam, J.C. Silva, T.M. Alvarez, R. Ruller, G.M.
Giesel, H. Verli, F.M. Squina, R.A. Prade, M.T. Murakami, Thermal-induced
[32]
[33]
[34]
[35]
[36]
[37]
[38]
[39]
[40]
[41]
[42]
[43]
[44]
[45]
[46]
[47]
[48]
[49]
[50]
[51]
[52]
[53]
1053
1054